Acne
Actinic Keratosis
Aesthetics
Alopecia
Atopic Dermatitis
Buy-and-Bill
COVID-19
Case-Based Roundtable
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Drug Watch
Eczema
General Dermatology
Hidradenitis Suppurativa
Melasma
NP and PA
Pediatric Dermatology
Pigmentary Disorders
Practice Management
Precision Medicine and Biologics
Prurigo Nodularis
Psoriasis
Psoriatic Arthritis
Rare Disease
Rosacea
Skin Cancer
Vitiligo
Wound Care

Advancing Care in Pediatric Plaque Psoriasis: Emerging Treatments and Management Strategies  : Episode 1

Opinion

Video

September 16, 2024

Psychosocial Impact of Plaque Psoriasis in Younger Children

Author(s):

Karan Lal, DO, MS, FAAD,Helen T Shin, MD

Karan Lal, DO, and Helen T Shin, MD, discuss how to address the psychosocial effects of plaque psoriasis on children and their families, exploring effective resources and interventions for support.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

Now Viewing

EP: 1.Psychosocial Impact of Plaque Psoriasis in Younger Children

EP: 2.Overview of the Prevalence of Pediatric Plaque Psoriasis

EP: 3.Navigating Treatment Algorithms: Balancing Provider Preferences and Clinical Guidelines

EP: 4.Diagnostic Challenges in the Management of Pediatric Plaque Psoriasis

EP: 5.Adult vs Pediatric Plaque Psoriasis Treatment Challenges

EP: 6.Early Diagnosis and Management, Unmet Needs and Treatment Challenges in Pediatric Plaque Psoriasis

EP: 7.Examining Molecular Differences in PDE4 Inhibitors in Pediatric Patients with Plaque Psoriasis

EP: 8.Exploring the Role of MOA and PDE4 Pathways in Pediatric Patients with Plaque Psoriasis

EP: 9.Provider Aspirations for Future Treatments and Clinical Investigations into Pediatric Plaque Psoriasis

EP: 10.Facing Challenges in Pediatric Plaque Psoriasis

Video content above is prompted by the following:

How do you approach the psychosocial impacts of plaque psoriasis on children and their families, and what resources or interventions are beneficial?

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!

Related Videos

Current Unmet Needs and Emerging Solutions in Atopic Dermatitis Management

Implementation Factors Affecting Ruxolitinib Adoption in Pediatric Dermatology Practice

Regulatory Challenges and Clinical Differentiators for Pediatric Atopic Dermatitis Treatments

Evaluating the Impact of Topical JAK Inhibitors on Pediatric Atopic Dermatitis Guidelines

The Future of Pediatric Atopic Dermatitis Treatment and Emerging Therapies

What Lies Ahead for GPP Diagnosis and Management

Case 3: High-Risk Patient with GPP Treatment Approach

Future Directions for IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis Care

Future Perspectives: Can Innovative Topical Therapies Like Ruxolitinib Reduce Systemic Treatment Dependency in Pediatric AD?

Treatment Escalation and De-escalation Strategies in Pediatric AD: Positioning Ruxolitinib Cream in Clinical Decision-Making